🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Several professionals stated the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the service has taken down problematic material and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at residence.

After minutes of entering one community, a seller shared contact information, where the majority of transactions occur. The seller sent an guidebook and promised shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Details and Costs

Within these groups, posts display black plastic parcels with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially serious medical dangers”.